Author/Authors :
Saleem , Saad Department of Internal Medicine - Sunrise Hospital and Medical Center, Las Vegas, NV, United States , Ishtiaq , Rizwan Department of Internal Medicine - St. Vincent Mercy Medical Center, Toledo, OH, United States , Inayat, Faisal Allama Iqbal Medical College, Lahore, Pakistan , Aziz , Muhammad Division of Gastroenterology and Hepatology - University of Toledo Medical Center, Toledo, OH, United States , Bleibel, Wissam Department of Internal Medicine - St. Vincent Mercy Medical Center, Toledo, OH, United States
Abstract :
The coronavirus was first identified as the cause of pneumonia in Wuhan, a town in the
Hubei Province of China, in December 2019. It usually has respiratory symptoms such as
myalgia, headache, cough, and dyspnea. In the medical literature, digestive symptoms and liver
disease have been reported in Coronavirus disease in 2019 (COVID-19) patients. In this review
article, we summarized the recent studies of gastrointestinal and hepatic manifestations
and management of COVID-19. The most common gastrointestinal symptoms were poor
appetite/anorexia, nausea/vomiting, diarrhea, and abdominal pain. Elevated aminotransferase
has been reported in patients with COVID-19. COVID-19 gastrointestinal and hepatic
management is usually symptomatic except for high-risk populations such as patients with
inflammatory bowel disease or autoimmune hepatitis, which require special attention.
Keywords :
Gastrointestinal , Liver , COVID-19 , Coronavirus
